Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-10-11
|
pubmed:abstractText |
Seventy-four patients from January 1975 through December 1982, with clinical Stage III Mo non-small cell carcinoma of the lung were treated at our Medical Center with a course of pre-operative radiation therapy to be followed by surgical resection. Radiation therapy consisted of delivering a total dose of 40 Gy with 200 cGy per fraction over a period of 4 weeks to the primary tumor in the lung and the regional lymph nodal areas. Surgical resection was attempted 4 weeks later. Fifty-eight percent of the patients had squamous cell carcinoma whereas the remaining had other histologies like adenocarcinoma, large cell carcinoma, or a combination thereof. All the patients except two were followed up to a minimum of 5 years or until death. Sixty-four patients (82%) had T3 tumors whereas mediastinal nodal involvement was found in 41 patients (55%). Fifteen patients (20%) did not have the operation because of tumor progression, patient's refusal or death. All but two surgically treated patients had tumor resection. Of these 19% had histologically negative specimens, 9 patients (16%) had microscopic disease only, and 37 patients had gross residual disease at the time of surgery. The actuarial 5-year survival and recurrence-free survival rates for the entire group were 20% and 24%, respectively. Patients with a pathologic response had an actuarial recurrence-free survival rate of 53% at 5 years whereas only 17% of those with gross residual disease at surgery had remained recurrence-free at 5 years. One-half of the patients with clinically uninvolved nodes were living recurrence-free at 5 years whereas only 20% of the patients with N2 disease did so. The patterns of failure according to the histology and stage of the disease will be presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
287-92
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2168353-Adenocarcinoma,
pubmed-meshheading:2168353-Adult,
pubmed-meshheading:2168353-Aged,
pubmed-meshheading:2168353-Aged, 80 and over,
pubmed-meshheading:2168353-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:2168353-Carcinoma, Small Cell,
pubmed-meshheading:2168353-Carcinoma, Squamous Cell,
pubmed-meshheading:2168353-Combined Modality Therapy,
pubmed-meshheading:2168353-Female,
pubmed-meshheading:2168353-Humans,
pubmed-meshheading:2168353-Lung Neoplasms,
pubmed-meshheading:2168353-Male,
pubmed-meshheading:2168353-Middle Aged,
pubmed-meshheading:2168353-Preoperative Care,
pubmed-meshheading:2168353-Survival Rate
|
pubmed:year |
1990
|
pubmed:articleTitle |
Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: long-term results and patterns of failure.
|
pubmed:affiliation |
Dept. of Therapeutic Radiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.
|
pubmed:publicationType |
Journal Article
|